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Scavenger receptor A (SR-A) is a key transmembrane receptor
in the endocytosis of lipids and contributes to the
pathogenesis of atherosclerosis. To assess its role in
hyperlipidemic chronic kidney disease, wild-type and SR-A-
deficient (knockout) mice underwent uninephrectomy
followed by either normal or high-fat diet. After 16 weeks of
diet intervention, hyperlipidemic wild-type mice presented
characteristic features of progressive nephropathy:
albuminuria, renal fibrosis, and overexpression of
transforming growth factor (TGF)-b1/Smad. These changes
were markedly diminished in hyperlipidemic knockout mice
and attributed to reduced renal lipid retention, oxidative
stress, and CD11c
þ cell infiltration. In vitro, overexpression of
SR-A augmented monocyte chemoattractant protein-1
release and TGF-b1/Smad activation in HK-2 cells exposed to
oxidized low-density lipoprotein. SR-A knockdown prevented
lipid-induced cell injury. Moreover, wild-type to knockout
bone marrow transplantation resulted in renal fibrosis in
uninephrectomized mice following 16 weeks of the high-fat
diet. In contrast, knockout to wild-type bone marrow
transplantation led to markedly reduced albuminuria,
CD11c
þ cell infiltration, and renal fibrosis compared to wild-
type to SR-A knockout or wild-type to wild-type bone
marrow transplanted mice, without difference in plasma lipid
levels. Thus, SR-A on circulating leukocytes rather than
resident renal cells predominantly mediates lipid-induced
kidney injury.
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Evidence has been increasingly provided that lipid accumula-
tion in kidney contributes to the progression of chronic
kidney disease (CKD).
1,2 Receptor-mediated lipid uptake is
the crucial step for lipid retention in the kidney, while this is
also caused by impaired cholesterol synthesis and inhibited
cholesterol efﬂux via adenosine triphosphate-binding cassette
transporter 1.
3–9 Several lines of data have indicated that the
speciﬁc transmembrane receptors, including scavenger re-
ceptor A (SR-A), CD36, lectin-like oxidized low-density
lipoprotein receptor-1, and C-X-C motif ligand 16, recognize
oxidative low-density lipoprotein (ox-LDL) based on ather-
ogenesis data.
5–9 Among these receptors, SR-A has been
identiﬁed on macrophages, endothelial cells, renal mesangial
cells, smooth muscle cells, dendritic cells, and renal tubular
epithelial cells.
6,10–13 Unlike other lipoprotein receptors,
SR-A is not regulated via negative feedback by cytoplasmic
cholesterol, and hence plays a key role in the formation of
foam cells.
12,14
Previous studies have shown that deletion of SR-A
decreased aortic wall plaque formation in mice fed with
high-fat diet and had no impact on the plasma lipid
level.
5,11,13 SR-A mediates endocytosis of ox-LDL, and
activates intracellular signaling pathways that contribute to
the atherosclerosis. Its mechanistic role in atherosclerosis
elicited by hyperlipidemia may suggest possible mechanisms
underlying the development of lipid-induced renal injury
and enhance the design of novel therapeutic strategies against
the progression of CKD. However, the effect of SR-A
deﬁciency on the progressive CKD of hyperlipidemia and
the underlying mechanism by which SR-A modulates renal
ﬁbrosis remains poorly understood.
Here, we use SR-A deﬁcient (SR-A
 / ) mice to test the
hypothesis that its deﬁciency will protect kidney from lipid
nephrotoxicity in progressive renal ﬁbrosis. We identiﬁed
SR-A as a key regulator in the renal lipid retention, CD11c
þ
cell recruitment, and oxidative stress in uninephrectomized
mice following 16 weeks of high-fat diet. Using genetic
approaches, we validated SR-A as a critical modulator of
transforming growth factor (TGF)-b1/Smad signaling and
monocyte chemoattractant protein-1 (MCP-1) in HK-2 cells
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1002 Kidney International (2012) 81, 1002–1014exposed to ox-LDL in vitro. In bone marrow (BM) chimeric
mice, SR-A
 /  to wild-type (WT) bone marrow transplanta-
tion (BMT) led to reduced albuminuria, renal CD11c
þ cell
ﬁltration, and kidney ﬁbrosis independent of plasma lipid
control.
RESULTS
SR-A deficiency ameliorated albuminuria and renal fibrosis in
uninephrectomized mice fed with high-fat diet
All SR-A
 /  mice were veriﬁed by Southern blot, western
blot, and immunohistochemistry (Supplementary Figure
S1a–c online). No signiﬁcant abnormalities in body weight,
morphology, renal histology, and plasma biochemical para-
meters were found as long as 24 weeks of age between WT
and SR-A
 /  mice (Figure 1c and e and Table 1). To evaluate
the effect of SR-A on the hyperlipidemic renal disease, WT
and SR-A
 /  mice at 8 weeks of age underwent unine-
phrectomy, followed by either normal or high-fat diet for 16
weeks, following the way as described.
15 Both WTand SR-A
 / 
mice that consumed high-fat diet showed markedly increased
body weights and systemic lipid levels when compared with
normal-diet mice (Table 1). There was no difference in
plasma lipids between WT and SR-A
 /  mice in the
conditions of either normal or high-fat diet, indicating that
SR-A did not affect the systemic lipid levels.
Consistent with the previous studies,
1,2,16 our data showed
that WTmice consuming high-fat diet developed progressive
albuminuria; however, this was lower at 8 weeks, and
signiﬁcantly reduced at 16 weeks of dietary intervention in
SR-A
 /  mice (Figure 1a). In addition, high-fat diet resulted
in markedly reduced kidney weight/body weight in WT
mice but was mild in SR-A
 /  mice (Figure 1b). Normal-diet
WT and SR-A
 /  mice did not show remarkably increased
albuminuria (Figure 1a). Morphologically, diet-induced
hyperlipidemia caused signiﬁcant glomerular mesangial
matrix accumulation and tubulointerstitial ﬁbrosis, but no
remarkable microvascular damage in kidney was observed
under light microscope. In contrast, SR-A deﬁciency
substantially reduced glomerular mesangial matrix index
and tubulointerstitium ﬁbrotic area compared with those of
WT mice with hyperlipidemia (Figure 1c–f). In addition,
persistent hyperlipidemia markedly increased the renal
deposition of ﬁbronectin, collagen I, and collagen III in
WT mice but was mild in SR-A
 /  mice (Figure 2a–d).
Importantly, the improved renal outcome in SR-A
 /  mice
was determined to be independent of hyperlipidemia, as diet-
induced high plasma levels of cholesterol and triglyceride
were similar in both mice genotypes (Table 1).
SR-A deficiency reduced renal lipid accumulation and
oxidative stress in uninephrectomized mice fed
with high-fat diet
Using Oil Red O staining, we detected increased lipids
retention in the kidneys of high-fat diet mice. SR-A deﬁciency
markedly reduced the renal lipid deposition compared with
WT mice consuming high-fat diet (Figure 3a and b),
indicating that the ameliorated kidney ﬁbrosis in SR-A
 / 
mice was correlated with lower renal lipid deposition.
Although the initial events involved in lipid-mediated renal
damage are unclear, oxidative stress is thought to be
especially important.
2,17 We revealed that mice consuming
high-fat diet showed a threefold increase in renal reactive
oxidative species (ROS), which was reduced in SR-A
 /  mice
(Figure 3c and d). To link the decreased ROS production to
lower lipid deposition in the kidneys, renal ROS and the
cholesterol content were quantiﬁed in the mice described
above. Our data showed that the mice with higher renal
cholesterol content correlated with higher ROS production in
the kidneys; in SR-A
 /  mice, renal ROS decreased with
lower content of cholesterol (Figure 3e). Also, mice consum-
ing high-fat diet showed a 3.5-fold increase in renal
malondialdehyde, a biomarker for oxidative stress,
18 which
was signiﬁcantly reduced in SR-A
 /  mice (Figure 3f). Thus,
these data suggested that SR-A deﬁciency decreased renal
cholesterol deposition and, consequently, reduced oxidative
stress in lipid-induced kidney injury.
SR-A deficiency decreased renal CD11c
þ cell filtration
and inflammation in uninephrectomized mice fed with
high-fat diet
One detrimental effect of oxidative stress is to cause
inﬂammation in the progressive kidney disease.
2,4,8 To test
the effect of SR-A deﬁciency on inﬂammatory proﬁle in
response to hyperlipidemia, mice plasma inﬂammatory
markers were examined. There was a twofold increase in
plasma tumor necrosis factor (TNF)-a and a fourfold
increase in interleukin (IL)-6 in WT mice consuming high-
fat diet compared with those of normal diet; in contrast, SR-
A deﬁciency markedly reduced plasma levels of TNF-a and
IL-6 (Table 1).
Recent data showed that a speciﬁc subset of CD11c
þ cells
are targets for free fatty acid–mediated increases in expression
of proinﬂammatory cytokine.
19 We revealed that mice
consuming high-fat diet showed signiﬁcantly increased
CD11c
þ cells number in glomeruli and tubulointerstitium,
which was substantially reduced in SR-A
 /  mice (Figure 4a).
Using a ﬂow cytometric analysis, we further found that both
CD11c
þ/CD68
þ and CD11c
 /CD68
þ cells increased in the
kidneys of mice fed with high-fat diet; however, SR-A
 / 
mice showed 60% reduction of CD11c
þ/CD68
þ and 39.3%
reduction of CD11c
 /CD68
þ cells compared with that of
WT mice (Figure 4b). The difference in the reduced levels of
the two subtype cells in ameliorated kidney implicated that
CD11c
þ macrophages are more important than resident
macrophages in lipid-induced kidney injury. In addition, SR-
A deﬁciency markedly reduced TNF-a and IL-6 levels in
kidneys compared with that of WTmice in groups of high-fat
diet (Figure 4c–e).
Several lines of study demonstrated that MCP-1 is a key
mediator for inﬂammation.
20–22 Our data showed that WT
mice consuming high-fat diet exhibited substantially in-
creased MCP-1 in plasma and kidney, and this increase was
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 /  mice (Table 1 and Figure 4c). To
better understand the effect of SR-A on MCP-1 expression in
high-fat diet mice, HK-2 cells, an immortalized proximal
tubular epithelial cell line, were incubated with ox-LDL after
forced expression or knockdown of SR-A. Consistent with
these ﬁndings in vivo, forced expression of SR-A increased the
lipids retention in HK-2 cells, and augmented the ox-LDL-
stimulated ROS generation and MCP-1 expression; in
600
400
200
U
r
i
n
a
r
y
 
a
l
b
u
m
i
n
/
c
r
e
a
t
i
n
i
n
e
 
(
m
g
/
g
)
0
81 6 2 4
P<0.01
P<0.001
P<0.001 P<0.001
P<0.01 P<0.01
40
30
20
10
0
T
u
b
u
l
o
i
n
t
e
r
s
t
i
t
u
m
 
f
i
b
r
o
s
i
s
 
a
r
e
a
 
(
%
)
P<0.05
1.0
0.8
0.6
0.4
K
i
d
n
e
y
 
w
e
i
g
h
t
/
b
o
d
y
 
w
e
i
g
h
t
 
(
%
)
M
e
s
a
n
g
i
a
l
 
m
a
t
r
i
x
 
i
n
d
e
x
 
(
%
)
0.2
0.0
30
20
10
0
Age (weeks)
SR-A
+/+ Normal diet
SR-A
+/+ Normal diet SR-A
+/+  Normal diet
SR-A–/– Normal diet
SR-A
–/– Normal diet
SR-A
–/–  Normal diet
SR-A+/+ High-fat diet
SR-A
+/+ High-fat diet
SR-A
+/+  High-fat diet
SR-A–/– High-fat diet
SR-A
–/– High-fat diet
SR-A
–/–  High-fat diet
SR-A +/+  Normal diet
SR-A
–/–  Normal diet
SR-A
+/+  High-fat diet
SR-A
–/–  High-fat diet
SR-A +/+  Normal diet
SR-A
–/–  Normal diet
SR-A
+/+  High-fat diet
SR-A
–/–  High-fat diet
SR-A
+/+ Normal diet SR-A
–/– Normal diet
SR-A
+/+ High-fat diet SR-A
–/ – High-fat diet
Figure 1|Albuminuria and renal histology in uninephrectomized mice at 16 weeks of dietary intervention. (a) Urinary albumin/
creatinine tested at time points indicated. (b) Kidney weight, normalized for body weight. (c) Representative histological photomicrograph
of glomeruli by periodic acid–Schiff staining. Scale bar¼19mm. (d) Bar graph summarizing the mesangial matrix index. (e) Representative
histological photomicrograph of kidney by Masson’s trichrome staining. Scale bar¼19mm. (f) Bar graph summarizing the percentage of
tubulointerstitial fibrosis area. Each bar represented the mean±s.e.m., n¼6–12 each group. SR-A, scavenger receptor A; SR-A
þ/þ, SR-A
wild-type mice; SR-A
 / , SR-A deficiency mice.
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LDL-stress (Figure 5a–e). To verify that the increased
expression of MCP-1 was caused by ox-LDL-induced ROS,
we examined MCP-1 in supernatant of cultured HK-2 cells
pretreated with antioxidant manganese superoxide dismutase
(MnSOD). Our data clearly showed that inhibition of
ox-LDL-stimulated ROS markedly decreased the MCP-1
production in the condition of either normal or over-
expression of SR-A (Figure 5e).
SR-A modulated TGF-b1/Smad signaling in tubular cells
exposed to ox-LDL
Previous evidence has demonstrated a link between
inﬂammatory environment and activation of TGF-b1/Smad
Table 1|Metabolic data of four groups at 16 weeks of experiment
Normal diet High-fat diet
Groups WT SR-A
 /  WT SR-A
 / 
Body weight (g) 34.6±1.5 35.2±1.6 55.2±1.8
a 54.5±1.7
BP (mmHg) 92.0±11.2 91.1±8.9 94.2±10.3 93.2±10.7
Plasma Cr (mmol/l) 67.5±4.3 66.2±4.8 106.0±7.8
a 82.4±6.5
b
Plasma triglyceride (mmol/l) 1.31±0.31 1.24±0.44 2.58±0.53
a 2.45±0.46
Plasma cholesterol (mmol/l) 2.35±0.43 2.42±0.36 6.73±0.62
a 6.36±0.53
Plasma MCP-1 (mg/l) 125.1±6.7 127.0±10.3 294.0±11.2
a 144.0±10.2
b
Plasma IL-6 (mg/l) 109.43±6.3 111.28±9.5 445.3±15.6
a 169.4±8.7
b
Plasma TNF-a (mg/l) 69.50±4.8 69.20±4.5 144.6±10.9
a 99.9±6.4
b
Abbreviations: BP, blood pressure; Cr, creatinine; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; SR-A, scavenger receptor A; SR-A
 / , SR-A deficiency mice;
TNF-a, tumor necrosis factor-a; WT, SR-A wild-type mice.
aPo0.05 versus WT mice fed with normal diet.
bPo0.05 versus WT mice fed high-fat diet.
Data are means±s.e.m.; n=12 in each group.
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Figure 2|Renal extracellular matrix deposition in uninephrectomized mice at 16 weeks of dietary intervention. (a) Representative
western blot analyses of fibronectin, collagen I, and collagen III in whole kidney lysate. Densitometric analysis of (b) fibronectin, (c) collagen
I, and (d) collagen III in western blot. Each bar represented the mean±s.e.m., n¼3 each group. b-Actin was used as loading control. SR-A,
scavenger receptor A; SR-A
þ/þ, SR-A wild-type mice; SR-A
 / , SR-A deficiency mice.
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Figure 3|Renal lipid accumulation and oxidative stress in uninephrectomized mice at 16 weeks of dietary intervention.
(a) Representative Oil Red O staining in the kidneys. Red, Oil Red O–positive cells; blue, hematoxylin counterstaining. Scale bar¼19mm.
(b) Bar graph summarizing Oil Red–positive cells in the kidney. (c) Representative photomicrograph of super oxidative anion assessed
by staining of dihydroethidium in the kidney. Scale bar¼19mm. (d) Bar graph summarizing dihydroethidium intensity in the kidney.
(e) Correlation between dihydroethidium intensity and the renal cholesterol content in the kidney, n¼24, r¼0.9261, 95% confidence
interval (CI) 0.8344–0.9679, Po0.01. (f) Malondialdehyde level in the kidney of mice at 16 weeks of experiment. Each bar represented the
mean±s.e.m., n¼6 each group. SR-A, scavenger receptor A; SR-A
þ/þ, SR-A wild-type mice; SR-A
 / , SR-A deficiency mice.
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23–26 The
current study showed that renal TGF-b1 was markedly increased
in WTmice but was mild in SR-A
 /  m i c ef e dw i t hh i g h - f a td i e t
(Figure 6a and b). Upregulated TGF-b1 was conﬁned largely to
the area where ﬁbrosis was evident. Coincident with the
increased presence of TGF-b1 ,t h ep e r c e n t a g eo fp h o s p h o r y l a t e d
Smad2/3 (p-Smad2/3)–positive nuclei was markedly increased
in the kidneys of WTmice at 16 weeks of high-fat diet, and this
increase was substantially reduced in SR-A
 /  mice (Figure 6c
and d). These data demonstrated that ameliorated renal ﬁbrosis
in hyperlipidemic SR-A
 /  mice related to the inhibited renal
TGF-b1/Smad signaling.
To further address that the renoprotective effect of SR-A
deﬁciency is associated with the inhibited TGF-b1/Smad
signaling, we stimulated HK-2 cells with ox-LDL after forced
expression or knockdown of SR-A. As shown in Figure 7a–d,
forced expressing SR-A enhanced TGF-b1 expression and
Smad2/3 activation. Conversely, knockdown of SR-A inhibi-
ted TGF-b1 expression and Smad2/3 activation in HK-2 cells
exposed to ox-LDL.
BM-derived leukocytes from SR-A
 /  mice decreased
albuminuria and renal fibrosis in uninephrectomized
mice fed with high-fat diet
To determine the contribution of SR-A from BM-derived
leukocytes to lipid-induced kidney injury, we performed
reciprocal BMT between WT and SR-A
 /  mice, using both
as donors and recipients of BMT. Neither SR-A deﬁciency nor
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Figure 4|Filtration of CD11c
þ cells and the proinflammatory markers in the kidney of uninephrectomized mice at 16 weeks of
dietary intervention. (a) Representative immunofluorescent staining of CD11c-positive cells in the kidney. Red, CD11c
þ cells; blue, 4,6-
diamidino-2-phenylindole (DAPI)-stained nuclei; scale bar¼19mm; G, glomeruli. (b) Representative flow cytometry analysis of CD11c
þ,
CD68
þ, and CD11c
þ/CD68
þ cells in the kidneys. The number in each field represented the mean percentage of the cell number from at
least three independent experiments. FITC, fluorescein isothiocyanate. (c) Renal cytosolic MCP-1, (d) TNF-a, and (e) IL-6 assayed by enzyme-
linked immunosorbent assay. Each bar represented the mean±s.e.m. for three independent experiments. IL-6, interleukin-6; MCP-1,
monocyte chemoattractant protein-1; SR-A, scavenger receptor A; SR-A
þ/þ, SR-A wild-type mice; SR-A
 / , SR-A deficiency mice; TNF-a,
tumor necrosis factor-a.
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erythrocyte and leukocyte counts or leukocyte differential
(Table 2). All mice that did not receive BMT died within 3
weeks of the transplant. At 4 weeks after BMT, peripheral
blood counts returned to normal and the mice underwent
uninephrectomy, and were then randomized to either normal
or high-fat diet for 16 weeks. Circulating leukocytes isolated
from WT to WT and WT to SR-A
 /  BMT mice showed
similar levels of SR-A expression compared with those of
leukocytes from untransplanted WTmice, indicating success-
ful BM replenishment (Figure 8a). Interestingly, SR-A
 /  to
WT BMT mice showed less albumin/creatinine ratio and
decreased glomerular mesangial matrix index and tubuloin-
terstitial ﬁbrosis area compared with those of WT to WT or
WT to SR-A
 /  BMT mice (Figure 8b–e). Indeed, albumin/
creatinine ratio, mesangial matrix index, and tubulointer-
stitial ﬁbrosis area in WT to SR-A
 /  BMT mice were
comparable to those of WT to WT BMT mice.
The role of BM-derived leukocyte SR-A in lipid-induced
kidney injury was further evaluated at 16 weeks of high-fat
diet in BMTmice. Renal content of cholesterol within kidney
was markedly reduced in SR-A
 /  to WT BMT mice
compared with that of WT to WT or WT to SR-A
 /  mice.
Interestingly, the percentage of renal CD11c
þ cells and CD68
macrophages in SR-A
 /  to WT BMT mice was substantially
less than those of WT to WT or WT to SR-A
 /  BMT mice
(Figure 9b and c). In addition, there were less MCP-1,
TNF-a, and IL-6 expressed in kidney and that in plasma of
Control
Control
ox-LDL
ox-LDL
60
P<0.01
P<0.01
P<0.01
P<0.01
P<0.01
P<0.01
P<0.01
P<0.05
40
20
0
4
5
3
2
M
C
P
-
1
 
(
μ
g
/
l
,
 
f
o
l
d
 
i
n
c
r
e
a
s
e
)
1
0
8
6
4
2
0
D
i
h
y
d
r
o
r
h
o
d
a
m
i
n
e
-
1
2
3
i
n
t
e
n
s
i
t
y
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
)
O
i
l
 
R
e
d
 
O
–
p
o
s
i
t
i
v
e
 
c
e
l
l
 
(
%
)
ox-LDL + si SR-A
ox-LDL + si SR-A
ox-LDL + pCAG-SR-A
Control ox-LDL
ox-LDL + si SR-A ox-LDL + pCAG-SR-A
ox-LDL + pCAG-SR-A
Control
ox-LDL
ox-LDL + si SR-A
ox-LDL + MnSOD
ox-LDL + pCAG-SR-A + MnSOD
ox-LDL + pCAG-SR-A
Control
ox-LDL
ox-LDL + si SR-A
ox-LDL + pCAG-SR-A
P<0.01
Figure 5|Effects of SR-A on lipid uptake, oxidative stress, and MCP-1 expression in HK-2 cells exposed to ox-LDL. (a) Representative
Oil Red O staining of HK-2 cells incubated with ox-LDL (10mmol/l). Red, Oil Red O–positive cells; blue, 4,6-diamidino-2-phenylindole (DAPI)
counterstaining; scale bar¼1mm. (b) Bar graph summarizing the percentage of Oil Red O–positive cells (300 cells were counted in three
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 /  to WT BMT mice compared with those of WT to
SR-A
 /  or WT to WT BMTmice (Figure 9d–f and Table 3).
These ﬁndings indicate that SR-A in circulating leukocytes
rather than in renal resident cells is the predominant
mediator in lipid-induced kidney injury.
DISCUSSION
An emerging body of evidence suggests that hyperlipidemia is
not only a risk factor for CKD progression, but also an
independent inducer for renal dysfunction.
1,2 We now
document in this study the proﬁbrotic effects of SR-A on
progressive renal ﬁbrosis elicited by hyperlipidemia in vivo
and in vitro. Our results indicate that SR-A is a key molecule
to modulate the oxidative stress, inﬂammation, and ﬁbrosis
in the pathogenesis of hyperlipidemic CKD. Our ﬁnding
suggests that SR-A deﬁciency protects mice from progressive
nephropathy of hyperlipidemia through inhibiting of
CD11c
þ cell recruitment and TGF-b1/Smad pathway.
Importantly, we validate the effectiveness of in vivo
reconstitution with SR-A
 /  mice BM-derived leukocytes in
lipid-induced nephropathy.
There is increasing evidence that ROS and other reactive
species are directly involved in redox signaling pathways that
promote inﬂammation. Our integrated in vivo and in vitro
experimental design identiﬁed SR-A as a key modulator for
tubular cells to uptake lipid. Consistent with previous
studies,
8,18,27,28 our ﬁnding revealed that SR-A modulated
ox-LDL-induced ROS generation in tubular cells, conse-
quently stimulated the expression of MCP-1, which is a key
mediator to recruit or activate inﬂammatory cells, and was
also important in generating proinﬂammatory cytokine.
20–22
Another major ﬁnding of this study is that CD11c
þ
cell–speciﬁc SR-A is a primary inducer of renal injury in
progressive nephropathy of hyperlipidemia. Emerging bodies
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the intensity of inﬂammation and the severity of renal
ﬁbrosis.
8,14,29,30 Indeed, the interstitial macrophages correlate
closely with ﬁbrosis.
6,15,31,32 Macrophages are phenotypically
and functionally heterogeneous, potentially able to promote
inﬂammation and ﬁbrosis or to prevent it via scavenging
activities.
10,30 Recently, a speciﬁc subset of CD11c
þ macro-
phages was shown to be recruited to obese adipose and
muscle tissue, and produced high levels of proinﬂammatory
cytokines that were linked to the tissue injury. CD11c
þ cell
ablation led to a marked decrease in inﬂammatory markers
locally and systemically.
19 Indeed, our data clearly showed
that SR-A
 /  mice fed with high-fat diet demonstrated
marked decrease in CD11c
þ cells ﬁltration and inﬂamma-
tory markers expression in both kidneys and plasma. In
chimeric study, SR-A
 /  to WT BMT led to reduced renal
CD11c
þ as well as CD68
þ cells ﬁltration, inﬂammatory
cytokines expression, albuminuria, and renal ﬁbrosis at 16
weeks of high-fat diet compared with those of WT to WTor
WT to SR-A
 /  BMTmice. These ﬁndings indicate that SR-A
on circulating leukocytes, such as CD11c
þ, rather than on
resident cells is the predominant mediator of lipid-induced
kidney injury. Although the markedly increased MCP-1 may
be the key molecule to recruit CD11c
þ in kidney, the precise
mechanism by which SR-A modulates CD11c
þ function is
necessary to determine in the future study.
In addition to the oxidative stress and inﬂammatory
proﬁle, we revealed that SR-A modulates TGF-b1/Smad
signaling. Awide array of studies has established that TGF-b1
modulates renal ﬁbrosis through its downstream Smad
signaling.
23,33,34 Indeed, our ﬁnding showed that deletion
of SR-A signiﬁcantly inhibited TGF-b1expression and there-
by diminished phosphorylated Smad2/3 in the ﬁbrotic
kidneys. Furthermore, the current study provided the ﬁrst
evidence that forced expression of SR-A directly activates
TGF-b1/Smad signaling in HK-2 cells exposed to ox-LDL
in vitro. Therefore, inhibition of TGF-b1/Smad pathway in
uninephrectomized SR-A
 /  mice with hyperlipidemia may
be a mechanism whereby SR-A promotes renal ﬁbrosis. These
ﬁndings implicate that SR-A/TGF-b1/Smad pathway is a
novel target in the treatment of renal ﬁbrosis on hyperlipi-
demic mice model.
Taken together, our data allow us to establish that SR-A
in tubular epithelial cells initiates lipid-induced oxidative
stress and MCP-1 release, which leads to more circulating
leukocytes recruited and promotes the renal ﬁbrosis.
Importantly, SR-A on circulating leukocytes rather than
renal resident cells predominantly mediates lipid-induced
kidney injury. These ﬁndings provide new insights into the
role of SR-A in hyperlipidemic kidney injury and open a
window of opportunity for a novel therapeutic intervention
for the progression of CKD.
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Figure 7|Effect of SR-A on TGF-b1/Smad signaling in HK-2
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Table 2|Peripheral blood counts on erythrocyte and leukocyte in mice at 4 weeks of BMT
Non-BMT mice BMT mice
Groups WT (n=12) SR-A
 /  (n=12) WT to WT (n=12) WT to SR-A
 /  (n=12) SR-A
 /  to WT (n=12)
RBC number ( 10
4/mm
3) 1115±73.5 1126±96.6 1184±110.8 1152±100.3 1239±121.4
Leukocyte number ( 10
2/mm
3)2 1 ±2.01 20±2.14 21±1.47 20±1.68 22±1.97
Lymphocyte (%) 86.5±4.91 86.2±6.13 85.6±5.23 87.5±7.06 87.1±4.64
Monocyte (%) 3.4±0.38 3.5±0.26 4.0±0.25 3.5±0.65 4.1±0.32
Neutrophil (%) 9.4±0.65 9.5±1.12 9.7±0.95 9.8±1.64 9.8±1.79
Abbreviations: BMT, bone marrow transplantation; RBC, red blood cell number; SR-A, scavenger receptor A; SR-A
 / , SR-A deficiency mice; WT, SR-A wild-type mice.
Data are means±s.e.m.
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Antibodies, plasmids, and other reagents
The antibodies and their sources are as follows: monoclonal anti-
mouse CD11c and polyclonal anti-mouse SR-A were from BD
Biosciences (Bedford, MA); monoclonal anti-mouse ﬁbronectin,
collagen I and III, TGF-b1, and polyclonal anti-mouse phosphoser-
ine Smad2/3 and Smad2 were from Santa Cruz (Santa Cruz, CA);
monoclonal anti-mouse b-actin was from Sigma-Aldrich (Buchs SG,
Switzerland); and monoclonal anti-human TGF-b1, polyclonal anti-
human phosphoserine Smad2/3, Smad2, SR-A, and monoclonal
anti-mouse CD68 were from Abcam (Cambridge, MA).
SR-A small interfering RNA (siRNA; sc-44116) and nonspeciﬁc
siRNA was purchased from Santa Cruz. pNVL3-MnSOD plasmid
35
was a kind gift from Dr Yewei Ma (Baylor College of Medicine,
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Figure 8|Albuminuria and renal histology in BMT uninephrectomized mice at 16 weeks of dietary intervention. (a) Representative
western blot analyses of SR-A expression in circulating leukocytes. (b) Urinary albumin/creatinine. (c) Representative histological
photomicrograph of kidney stained for glomerular mesangial matrix (periodic acid–Schiff stain). Scale bar¼19mm. (d) Bar graph
summarizing the mesangial matrix index (MMI) in periodic acid–Schiff–stained section. (e) Bar graph summarizing the percentage of
tubulointerstitial fibrosis area in trichrome-stained section. Each bar represents the mean±s.e.m. for at least six mice. BMT, bone marrow
transplantation; SR-A, scavenger receptor A; SR-A
þ/þ, SR-A wild-type mice; SR-A
 / , SR-A deficiency mice.
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macrophage scavenger receptor 1 (MSR1) gene (NM_138715) was
ampliﬁed from HK-2 genomic DNA by PCR using the HotMaster
Taq DNA polymerase (5 PRIME, Gaithersburg, MD), with the
following primers: 50-CATCAGGGATCCATGGAGCAGTGGGATC
ACTTTC-30 (forward) and 50-CATCAGGTTTAAACTTATAAAGT
GCAAGTGACTCCAG-30 (reverse). The 3763-bp PCR product was
cloned between the PmeI and BamHI site of the pCAG-GFP vector
(Addgene plasmid 16664), to generate pCAG-SR-A.
Ox-LDL was a kind gift from Dr Jizhong Chen
36 (Baylor College
of Medicine). Dihydrorhodamine-123 and dihydroethidium were
purchased from Invitrogen (Carlsbad, CA); Creatinine Companion
kit and urine albumin ELISA kit were purchased from Exocell
(Philadelphia, PA); malondialdehyde TBARS Assay Kit was pur-
chased from Cell Biolabs (San Diego, CA); RNeasy kit was purchased
from Qiagen (Valencia, CA); MCP-1, TNF-a, and IL-6 ELISA kits
were purchased from Phoenix Pharmaceuticals (Burlingame, CA);
cholesterol CII kit and L-type triglyceride H kit were purchased from
Wako Chemicals (Richmond, VA). All other reagents were purchased
from Sigma-Aldrich unless otherwise noted.
Animal studies
SRA
 /  mice and their wild-type control have been described
elsewhere.
13 To establish a lipid-induced kidney injury model,
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Figure 9|Renal lipid accumulation, leukocyte filtration, and cytokine expression in BMT uninephrectomized mice at 16 weeks
of dietary intervention. (a) Renal cholesterol content in the kidney. Percentage of (b) CD11c
þ and (c) CD68
þ cells in the kidneys
analyzed by flow cytometry. (d) Renal cytosolic MCP-1, (e) TNF-a, and (f) IL-6 assayed by enzyme-linked immunosorbent assay. Each bar
represented the mean±s.e.m. for at least six mice. BMT, bone marrow transplantation; IL-6, interleukin-6; MCP-1, monocyte chemoattractant
protein-1; SR-A, scavenger receptor A; SR-A
þ/þ, SR-A wild-type mice; SR-A
 / , SR-A deficiency mice; TNF-a, tumor necrosis factor-a.
Table 3|Metabolic data of the BMT mice at 16 weeks of dietary intervention
Normal diet High-fat diet
Groups
WT to WT
(n=6)
WT to SR-A
 / 
(n=6)
SR-A
 /  to WT
(n=7)
WT to WT
(n=6)
WT to SR-A
 / 
(n=6)
SR-A
 /  to WT
(n=5)
Body weight (g) 33.4±3.5 34.2±2.5 34.1±2.5 54.9±3.6
a 55.5±3.4
b 55.3±4.7
c
BP (mmHg) 92.5±10.3 92.7±9.3 92.0±11.5 92.2±10.7 94.2±10.8 93.1±8.9
Plasma Cr (mol/l) 62.5±5.3 66.5±6.4 63.5±4.7 110.4±6.5
a 106.0±7.8
b 96.2±8.5
c,d,e
Plasma triglyceride (mmol/l) 1.33±0.56 1.41±0.61 1.35±0.36 2.55±0.41
a 2.58±0.63
b 2.54±0.94
c
Plasma cholesterol (mmol/l) 2.45±0.48 2.39±0.63 2.49±0.46 6.76±0.93
a 6.79±0.69
b 6.72±0.76
c
Plasma MCP-1 (mg/l) 129.1±9.2 126.1±8.7 128.9±9.7 279.0±10.2
a 264.0±11.2
b 167.0±10.3
c,d,e
Plasma IL-6 (mg/l) 112.5±6.7 108.3±6.9 110.4±6.3 469.9±8.7
a 439.1±14.6
b 211.2±9.5
c,d,e
Plasma TNF-a (mg/l) 73.5±6.9 69.0±7.8 68.5±7.1 159.9±6.8
a 174.6±10.1
b 99.20±14.6
c,d,e
Abbreviations: BMT, bone marrow transplantation; BP, blood pressure; Cr, creatinine; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; SR-A, scavenger
receptor A; SR-A
 / , SR-A deficiency mice; TNF-a, tumor necrosis factor-a; WT, SR-A wild-type mice.
aPo0.05 versus WT to WT BMT mice fed with normal diet.
bPo0.05 versus WT to SR-A
 /  BMT mice fed with normal diet.
cPo0.05 versus SR-A
 /  to WT BMT mice fed with normal diet.
dPo0.05 versus WT to WT BMT mice fed with high fat diet.
ePo0.05 versus WT to SR-A
 /  BMT mice fed with high-fat diet.
Data are means±s.e.m.
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 /  mice underwent
uninephrectomy, and were then randomized into four groups:
group 1: WT, normal diet (standard chow containing 270mg
cholesterol per kg); group 2:S R - A
 / , normal diet; group 3:W T ,
high-fat diet (standard chow supplemented with 10% saturation oil
and 1% cholesterol);
15,37 and group 4:S R - A
 / , high-fat diet; 12
animals in each group. Following 16 weeks of diet intervention,
blood and kidneys were harvested for next experiment. All animal
studies were carried out with the review and approval of the animal
care and use committee of Sun Yat-sen University and Baylor
College of Medicine.
Blood biochemical components and blood pressure analysis
Plasma creatinine, MCP-1, TNF-a, IL-6, cholesterol, and triglyceride
were measured using the kits described above according to the
manufacturer’s protocol. Systolic blood pressure was measured
through a tail-cuff apparatus (AD Instruments, Bella Vista,
Australia) in conscious mice. Systolic blood pressure values were
derived from an average of ﬁve measurements per animal.
Morphometric studies
With periodic acid–Schiff–stained sections, light microscopic views
of 40 consecutive glomerular cross-sections per mouse were scanned
into a computer. Glomerular and mesangial matrix area were
quantiﬁed in a blinded fashion using an image analysis system (NIS
Elements, Nikon, Sendai, Japan). Mesangial matrix index was
calculated as the ratio of mesangial area to tuft area  100 (% area).
The percentage of tubulointerstitial ﬁbrosis area was determined
on Masson’s trichrome-stained sections using a computer-aided
manipulator program as described above. In all, 20 ﬁelds of
tubulointerstitial area under low magniﬁcation ( 200) per mouse
were scanned to analyze the ﬁbrosis area.
Oil Red O staining
Frozen sections were stained by Oil Red O and quantiﬁed as
described with modiﬁcation.
38 Brieﬂy, Oil Red O–positive cells were
counted in at least 20 high-power ( 400) ﬁelds with a micro square
scale plate (0.0625mm
2) arranged in ocular lens. The number of Oil
Red O–positive cells in kidney was represented as cells/mm
2.
Immunohistochemistry and immunoblot analysis
Association of ﬁbrosis protein was assessed by western blot and
immunohistochemistry as described previously.
39,40
Lipid extraction and lipid peroxidation determination
Total lipid was extracted from kidneys by the method of Bligh and
Dyer.
41 Lipoperoxides in renal tissue were determined by measure-
ment of malondiadehyde–thiobarbituric acid using a kit described
above according to the manufacturer’s protocol.
Determination of ROS
Distribution of superoxide anion in kidney was stained by
dihydroethidium (5mmol/l) on frozen sections and the intensity
was analyzed at 585nm with a confocal microscopy. Quantiﬁcation
of superoxide anion in HK-2 cells was analyzed on the coverslips
stained with dihydrorhodamine-123 (5mmol/l). Fluorescence of the
dihydrorhodamine-123 oxidation product was measured with a
multi-channel analyzer using 490nm excitation and recording the
ﬂuorescence emission at the optimum (525±3nm).
Cell culture and plasmid, siRNA transfection
HK-2 cells (human renal proximal tubular epithelial cells) were
cultured as described.
42 Cells were grown to conﬂuence and serum-
deprived for 48h before experimental manipulation. All experi-
ments were performed under serum-free conditions. Under these
conditions, the cells remained viable in a nonproliferation state.
Nonspeciﬁc siRNA, SR-A siRNA, pCAG-SR-A, and pNVL3-MnSOD
plasmid were transfected into HK-2 cells using Lipofectamine
2000TM (Invitrogen) at a ﬁnal concentration of 30nmol/l.
Flow cytometry
Mice renal cells were prepared as described.
43 The following primary
monoclonal antibodies were used for labeling cell suspensions:
monoclonal anti-CD11c (1:100), which recognizes the circulating
cells, and monoclonal anti-CD68 (1:100), which recognize resident
macrophages. Cells at a concentration of 5–10 10
6/ml were
incubated with primary antibody in Hank’s balanced salt solution
with 1% fetal calf serum (HBSS-FCS) at 41C for 45min. After three
washes in HBSS-FCS, cells were resuspended at the same
concentration and incubated with ﬂuorescein-conjugated second
antibody (Invitrogen) with 1% bovine serum albumin for 30min at
41C. The cells were washed twice in HBSS-FCS and ﬁnally
suspended at B1 10
6cells/ml in protein-free HBSS for ﬂow
cytometry (BD Biosciences) analysis.
BMT protocol
Male WT C57BL/6 (The Jackson Laboratory, Sacramento, CA) and
SR-A
 /  mice, 8 weeks old, underwent total body lethal irradiation
(9.5Gy) to eliminate endogenous BM stem cells and circulating
leukocytes. BM cells used for repopulation were extracted from the
femur and tibia of 12 WT and 12 SR-A
 /  mice. Irradiated mice
were injected intravenously with 10
7 BM cells from either WT or
SR-A
 /  mice. At 4 weeks after BMT, blood and leukocyte counts
returned to normal (Table 2). Therefore, uninephrectomized
operation was performed 4 weeks after BMT. All irradiated mice
that were not injected with transplanted BM cells died within 2 to
3 weeks after radiation.
Statistical analyses
Data obtained from this study were expressed as the mean±s.e.m.
Statistical analyses were performed using one-way analysis of
variance followed by Tukey’s multiple comparison test with
GraphPad Prism 5.0 (GraphPad Software, San Diego, CA) to
determine the signiﬁcance of differences in multiple comparisons.
A P-value of o0.05 was considered statistically signiﬁcant.
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